Dual inhibitory activity of sitafloxacin (DU-6859a) against DNA gyrase and topoisomerase IV of Streptococcus pneumoniae
Open Access
- 1 October 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (4) , 533-536
- https://doi.org/10.1093/jac/44.4.533
Abstract
The in-vitro inhibitory activities of sitafloxacin (DU-6859a) and other quinolones against Streptococcus pneumoniae DNA gyrase and topoisomerase IV were measured. IC50s of levofloxacin, ciprofloxacin, sparfloxacin and tosufloxacin against DNA gyrase were almost three to 12 times higher than those against topoisomerase IV. On the other hand, sitafloxacin showed dual inhibitory activity against both enzymes and its IC50s were the lowest among those of the quinolones tested. These results suggest that sitafloxacin is an effective agent against pneumococcal infections and that the incidence of drug-resistant mutants is low.Keywords
This publication has 12 references indexed in Scilit:
- Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1997
- Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolonesAntimicrobial Agents and Chemotherapy, 1997
- High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrAAntimicrobial Agents and Chemotherapy, 1996
- Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1996
- Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve methodJournal of Antimicrobial Chemotherapy, 1996
- Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibitionAntimicrobial Agents and Chemotherapy, 1994
- Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolonesMolecular Microbiology, 1994
- Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolatesAntimicrobial Agents and Chemotherapy, 1992
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990